Candida auris Isolates Resistant to Three Classes of Antifungal Medications --- New York, 2019

Jan 09, 2020
Although rare, Candida auris resistant to all three classes of commonly used antifungal drugs was identified in three patients in New York. CDC considers C. auris an urgent threat, the highest category of concern.

Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?